Abstract
A simple and efficient catalytic method has been designed for the synthesis of a series of novel β-aminoketones using 3-aryl-4-formylsydnone, primary aromatic amine and cyclohexanone in the presence of ceric ammonium nitrate (CAN). The percentages of syn and anti isomers formed were elucidated using 1H NMR spectral studies. The anti isomer was the major product.
Keywords: Ceric ammonium nitrate, syn/anti conformation, Sydnone, β-Aminoketone.
Letters in Organic Chemistry
Title:Ceric Ammonium Nitrate Catalysed Stereoselective Synthesis of β-Aminoketones Using 3-Aryl-4-Formylsydnones
Volume: 11 Issue: 4
Author(s): Atukuri Dorababu, Ravindra R. Kamble, Pramod P. Kattimani, Mahadevappa Y. Kariduraganavar and Atulkumar A. Kamble
Affiliation:
Keywords: Ceric ammonium nitrate, syn/anti conformation, Sydnone, β-Aminoketone.
Abstract: A simple and efficient catalytic method has been designed for the synthesis of a series of novel β-aminoketones using 3-aryl-4-formylsydnone, primary aromatic amine and cyclohexanone in the presence of ceric ammonium nitrate (CAN). The percentages of syn and anti isomers formed were elucidated using 1H NMR spectral studies. The anti isomer was the major product.
Export Options
About this article
Cite this article as:
Dorababu Atukuri, Kamble R. Ravindra, Kattimani P. Pramod, Kariduraganavar Y. Mahadevappa and Kamble A. Atulkumar, Ceric Ammonium Nitrate Catalysed Stereoselective Synthesis of β-Aminoketones Using 3-Aryl-4-Formylsydnones, Letters in Organic Chemistry 2014; 11 (4) . https://dx.doi.org/10.2174/1570178611999140221163716
DOI https://dx.doi.org/10.2174/1570178611999140221163716 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Technology in the Discovery and Development of Novel Antibacterials
Current Drug Targets Acknowledgements and Editorial (Exploring the Role of “Treatment as Prevention”)
Current HIV Research Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers The Role of Universal Stress Proteins in Bacterial Infections
Current Medicinal Chemistry Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal Nonprofit Pharma: Solutions to What Ails the Industry
Current Medicinal Chemistry Formulation of Nanoparticles Against TB - A Review
Recent Patents on Inflammation & Allergy Drug Discovery The Cell-Wall Core of Mycobacterium tuberculosis in the Context of Drug Discovery.
Current Topics in Medicinal Chemistry Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers
Current Drug Metabolism Inhibitors of Mycothiol-S-Conjugate Amidase and Related Genes
Current Medicinal Chemistry - Anti-Infective Agents Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design
Current Medicinal Chemistry Collocating Novel Targets for Tuberculosis (TB) Drug Discovery
Current Drug Discovery Technologies Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease
Current Respiratory Medicine Reviews A Computational Molecular Docking Studies on the Tryparedoxin Peroxidase of <i>Leishmania donovani</i> Responsible for Visceral Leishmaniasis in Human
Letters in Drug Design & Discovery Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products
Current Pharmaceutical Design Short Antimicrobial Peptides
Recent Patents on Anti-Infective Drug Discovery Artificial Neural Networks to Optimize Formulation Components of a Fixed- Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion
Current Drug Discovery Technologies Imaging Reporters and Multimodal Molecular Bio-Imaging: A Database of Available Probes for Multi-Modality Bio-Imaging of Reporter Gene Expression
Recent Patents on Medical Imaging Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design